Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
302.50    0.00 (0.00%)
Bid:
302.50
Ask:
303.00
Spread: 0.50 (0.165%)
Market Cap: £178.58m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Form 8.5 (EPT/RI) Treatt plc

Today 12:00

RNS Number : 9494H
Peel Hunt LLP
11 June 2026
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Peel Hunt LLP

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Treatt plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Treatt plc

(d) Date dealing undertaken:

10 June 2026

 

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary Shares

Purchases

6,351

303.00 GBx

302.24 GBx

Ordinary Shares

Sales

6,353

303.45 GBx

302.50 GBx

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

Date of disclosure:

11 June 2026

 

Contact name:

Lesah Munyakazi

 

Telephone number:

+44 (0) 20 7418 8900

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERUARKRNUUNARR
Date   Source Headline
28th Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20257:00 amRNSTransaction in Own Shares
17th Apr 20257:00 amRNSTransaction in Own Shares
16th Apr 20257:00 amRNSTransaction in Own Shares
15th Apr 20257:00 amRNSTransaction in Own Shares
14th Apr 20257:00 amRNSTransaction in Own Shares
11th Apr 20255:34 pmRNSReplacement: Transaction in Own Shares
11th Apr 20252:25 pmRNSHolding(s) in Company
11th Apr 20257:00 amRNSTransaction in Own Shares
10th Apr 20259:07 amRNSHolding(s) in Company
10th Apr 20257:01 amRNSShare Buyback Programme
10th Apr 20257:00 amRNSTrading Update
25th Mar 202511:30 amRNSVoting Rights and Capital
24th Mar 20257:00 amRNSDirectorate Change
19th Mar 20253:33 pmRNSDirector/PDMR Shareholding
6th Feb 20254:18 pmRNSHolding(s) in Company
4th Feb 202511:55 amRNSHolding(s) in Company
30th Jan 20254:17 pmRNSResult of AGM
30th Jan 20257:00 amRNSAGM Trading Update
20th Dec 202411:24 amRNSNotification of Transactions of Directors
17th Dec 20244:07 pmRNSAnnual Report and Notice of Annual General Meeting
17th Dec 20241:44 pmRNSNotification of Transactions of Directors
4th Dec 20241:47 pmRNS2024 Final Dividend
4th Dec 20247:00 amRNSFull Year Results
2nd Dec 20247:00 amRNSBlock Listing Six Monthly Return
2nd Dec 20247:00 amRNSBlock Listing Six Monthly Return
15th Nov 20247:00 amRNSBoard Change
16th Oct 202412:00 pmRNSChange in Director's Duties
10th Oct 20247:00 amRNSTrading Update
24th Sep 20242:06 pmRNSDirector/PDMR Shareholding
20th Aug 202411:06 amRNSNotification of Transactions of Directors
12th Jul 202410:49 amRNSDirector/PDMR Shareholding
4th Jun 202410:35 amRNSBlock Listing Six Monthly Return
4th Jun 202410:25 amRNSBlock Listing Six Monthly Return
3rd Jun 20247:00 amRNSDavid Shannon joins as CEO
14th May 20247:00 amRNSHalf Year Results
30th Apr 20244:02 pmRNSVoting Rights and Capital
10th Apr 20247:00 amRNSHalf Year Trading Update & Notice of Results
19th Mar 20243:40 pmRNSNotification of Transactions of Directors
4th Mar 20247:00 amRNSAppointment of Chief Executive Officer
13th Feb 20249:35 amRNSHolding(s) in Company
31st Jan 20242:41 pmRNSNotification of Transaction of PDMR
25th Jan 20243:49 pmRNSResult of AGM
25th Jan 20247:00 amRNSAGM Trading Update
23rd Jan 20241:57 pmRNSTotal Voting Rights
21st Dec 20232:07 pmRNSNotification of Transaction of Director
15th Dec 20236:09 pmRNSNotification of Transactions - Replacement
15th Dec 20234:42 pmRNSNotification of Transactions of Directors
13th Dec 20237:00 amRNSInterim Chief Financial Officer Appointment
12th Dec 20234:24 pmRNSAnnual Report and Notice of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.